With the end of the health emergency in Brazil caused by the Covid pandemic, the use of Coronavac will be restricted to children and adolescents from 5 to 18 years old.
The change was announced by the Minister of Health, Marcelo Queiroga.
The Ministry of Health asked Anvisa to authorize for another year for this public the emergency use of Coronavac, a vaccine made by the Chinese Sinovac produced in Brazil in partnership with the Butantan Institute.
The ministry said it did not include the primary regimen in adults in the order. The regulatory agency has yet to approve this request.
"There is still a lack of scientific evidence to support maintaining CoronaVac for people older than 18," said the ministry.
Translated by Kiratiana Freelon